Polypharmacy considerations are particularly relevant in the patient populations typically prescribed semaglutide
* Beneficios a largo plazo: Ms all del control glucmico y la prdida de peso, los GLP-1 RA han mostrado beneficios a largo plazo en la reduccin de eventos cardiovasculares, la progresin de la enfermedad renal y posiblemente en la salud neurolgica
"Those results suggest that the efficacy of ecnoglutide might be similar or even better than semaglutide in glycemic control," Jiang said
Here is what to do when things do not go as planned
During this stage, 300 articles were excluded due to irrelevance to the research question or failure to meet the inclusion criteria (22 clinical trials, 43 reviews or other unfitting literature, 112 wrong cell type, 49 wrong focus, 10 wrong drugs, 57 in vivo, 2 retractions, 3 no abstract and 2 not peer reviewed yet)